Domain Therapeutics' Series B Round

Domain Therapeutics raised a round of funding on February 06, 2004.

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). D…

Articles about Domain Therapeutics' Series B Round: